Discover 1,444 paid clinical trials in Akron, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,444
A Safety and Tolerability Study of Jaktinib
for
Myelofibrosis
Location: Canton OH
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Sex: All
Age: 18+
Code: NCT05279001
Phase 1, Recruiting
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
for
Advanced Solid Tumors
Location: Canton OH, Detroit MI, Dayton OH, Cincinnati OH,
Sponsor: DualityBio Inc.
Sex: All
Age: 18+
Code: NCT05914116
Phase 1, Phase 2, Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
for
Acute Coronary Syndrome
Location: Canton OH, Cleveland OH, Toledo OH, Dearborn MI,
Sponsor: DalCor Pharmaceuticals
Sex: All
Age: 45+
Code: NCT05918861
Phase 3, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
for
Non-squamous Non-small Cell Lung Cancer
Location: Canton OH, Hamilton, Buffalo NY, Grand Rapids MI,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06627647
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
for
Major Depressive Disorder (MDD),
Location: North Canton OH, Independence OH, Allentown PA,
Sponsor: Seaport Therapeutics
Sex: All
Age: 18 - 65
Code: NCT07065240
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
A Study to Evaluate the Safety and Efficacy of ALKS 7290 as an Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder
for
Major Depressive Disorder (MDD)
Location: North Canton OH, Jacksonville FL
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 65
Code: NCT07901179
Phase 2, Recruiting
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
for
Attention Deficit Disorder With Hyperactivity (ADHD)
Location: North Canton OH, Detroit MI, Decatur GA,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 65
Code: NCT07755410
Phase 2, Recruiting
Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
for
PTSD - Post Traumatic Stress Disorder, PTSD, PTSD Symptoms,
Location: North Canton OH, Chicago IL, New York NY, The Bronx NY,
Sponsor: COMPASS Pathways
Sex: All
Age: 18+
Code: NCT07570654
Phase 2, Phase 3, Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Location: North Canton OH, Massillon OH, Canton OH, Orrville OH,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222566
Phase 3, Recruiting
Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC
for
Chemotherapy-induced Nausea and Vomiting
Location: Massillon OH, Gettysburg PA, Bethesda MD, Skokie IL,
Sponsor: Xiamen LP Pharmaceutical Co., Ltd
Sex: All
Age: 18+
Code: NCT05199818
Phase 3, Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
for
Triple-Negative Breast Cancer
Location: Massillon OH, Canton OH, Zanesville OH, Maumee OH,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06393374
Phase 3, Recruiting
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
for
Breast Cancer, Lung Cancer, Multiple Myeloma, Ovarian Cancer,
Location: Massillon OH, Canton OH, Cleveland OH, Evanston IL
Sponsor: Carevive Systems, Inc.
Sex: All
Age: 18+
Code: NCT05974150
Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial